Fed hawkishness may have peaked, inflation could follow: Kevin Mahn
Hennion & Walsh Asset Management president and CIO Kevin Mahn warns more volatility could be in store for the stock market on 'The Claman Countdown.'
Mainstream media has another meltdown over Elon Musk's Twitter takeover
'Can't cancel Rob Smith' podcast host Rob Smith discusses the media's meltdown as Elon Musk is set to acquire Twitter and weighs in on the military's vaccine mandate.
American Red Cross spokesperson Evan Peterson on Hurricane Ian: We're in reactive mode
American Red Cross spokesperson Evan Peterson discusses the damage in Florida caused by Hurricane Ian and how the organization will assist residents in the aftermath of the storm.
Biogen's new Alzheimer's drug could take 'some time' to reach Medicare market: Laura Chico
Wedbush Securities Senior Vice President of biotech equity research Laura Chico says questions remain about the benefits and risks of Biogen's experimental Alzheimer's drug.
Grove's CVS deal proves zero waste trend plays in the big market: Stuart Landesberg
Grove Collaborative CEO Stuart Landesberg discusses the company's mission and partnership with CVS stores across the U.S. on 'The Claman Countdown.'
Dr. Marc Siegel on COVID booster messaging: 'The politicians keep confusing us'
Fox News contributor Dr. Marc Siegel clears up COVID-19 booster vaccine confusion and discusses a recent study linking COVID to a higher Alzheimer's risk.
Court rejects DOJ's request to halt UnitedHealth's merger with Change Healthcare
A district court judge on Monday denied the Department of Justice's request to stop the planned merger of UnitedHealth Group and Change Healthcare.
Dr. Siegel: The government has promoted immunity 'the wrong way'
Fox News medical contributor Dr. Marc Siegel discusses the White House pushing omicron booster shots.
Rand Paul: Forces were more concerned with election than trying to prevent COVID deaths
Kentucky Republican Sen. Rand Paul reacts to critics saying the Democrats and FDA delayed the COVID-19 vaccine to hurt former President Trump on 'Kudlow.'
Botox alternative 'Daxxify' best for 'busy' patients who want 'longer lasting' filler: Plastic surgeon
Board-certified plastic surgeon Dr. Douglas Steinbrech says a newly FDA-approved anti-wrinkle drug lasts up to six to nine months, instead of three like competitor Botox.
Yearly COVID vaccinations 'better not' become compulsory: Dr. Siegel
Fox News medical contributor Dr. Marc Siegel says 'good news' has been overlooked about the possibility of new COVID-19 variants.
Illumina to appeal after European Commission prohibits $7.1 billion GRAIL acquisition
Illumina announced Tuesday it plans to appeal the European Commission's decision to prohibit the company's acquisition of cancer detection company GRAIL.
FTC appeals ruling in case challenging Illumina's acquisition of GRAIL
The Federal Trade Commission on Friday filed a notice of appeal in its case challenging Illumina's $7.1 billion acquisition of cancer detection company GRAIL.
Amazon, Apple, Google are 'cash flow defensive' and worth buying: Expert
Evercore ISI senior managing director Mark Mahaney provides his top technology picks and investment strategy in an inflation-driven market on 'Varney & Co.'
Dr. Siegel on Fauci warning of bad flu season: 'I'm concerned'
Fox News contributor Dr. Marc Siegel shares his thoughts on the upcoming flu season, new COVID booster shots to target the Omicron variant and the status of monkeypox cases
Illumina wins FTC GRAIL case in $7.1 billion deal
Illumina said Thursday it has won in the Federal Trade Commission's case challenging its $7.1 billion acquisition of cancer detection company GRAIL.
Rep. Burgess: We're not at the ending of this spending road
Rep. Michael Burgess, R-Texas, discusses Biden's spending plans as inflation lingers, UC Berkeley requiring students who haven't received a flu shot to mask up, and the origins of COVID-19.
Dr. Siegel: No way to measure damage COVID lockdowns did to kids
Fox News medical contributor reacts to Dr. Fauci saying COVID lockdowns did not harm children on 'Varney & Co.'
How is The Vitamin Shoppe appealing to younger demographics?
The Vitamin Shoppe CEO Sharon Leite explains the impact that inflation has had on how consumers approach health care products on 'Mornings with Maria.'
The Vitamin Shoppe CEO: ‘No question’ inflation impacts Americans’ physical, mental health
As retailers continue to face price increases and supply chain issues, The Vitamin Shoppe CEO Sharon Leite discusses how Americans are prioritizing their well-being.